Picture of Biolidics logo

8YY Biolidics Share Price

0.000.00%
sg flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-2.88%
3m-9.13%
6m-16.25%
1yr-24.17%
Volume Change (%)
10d/3m-68.52%
Price vs... (%)
52w High-45.45%
50d MA-1.8%
200d MA-14.41%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-180.61%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Biolidics EPS forecast chart

Profile Summary

Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singapore’s Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    July 19th, 2009
    Public Since
    December 19th, 2018
    No. of Employees
    30
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    sg flag iconSingapore Exchange Securities Trading Ltd
    Shares in Issue
    744,758,836

    8YY Share Price Performance

    Upcoming Events for 8YY

    Biolidics Ltd Annual Shareholders Meeting

    Q1 2024 Biolidics Ltd Earnings Release

    Similar to 8YY

    Picture of AJJ Medtech Holdings logo

    AJJ Medtech Holdings

    sg flag iconSingapore Exchange Securities Trading Ltd

    Picture of Medtecs International logo

    Medtecs International

    sg flag iconSingapore Exchange Securities Trading Ltd

    Picture of Pasture Holdings logo

    Pasture Holdings

    sg flag iconSingapore Exchange Securities Trading Ltd

    Picture of Riverstone Holdings logo

    Riverstone Holdings

    sg flag iconSingapore Exchange Securities Trading Ltd

    Picture of Top Glove Bhd logo

    Top Glove Bhd

    sg flag iconSingapore Exchange Securities Trading Ltd

    FAQ